Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: Three-year results from the SPIRIT III randomised trial

EuroIntervention

Volumn 6, Issue SUPPL. J, 2010, Pages

  Lansky, Alexandra J ^a   Yaqub, Manejeh ^b   Hermiller, James B ^c   Smith Jr , Robert S ^b   Farhat, Naim ^c   Caputo, Ronald ^d   Williams, Jerome E ^e   Sanz, Mark ^f   Koo, Kai ^b   Sood, Poornima ^b   Sudhir, Krishnankutty ^b   Stone, Gregg W ^g  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ABBOTT VASCULAR   (United States)

^c Heart Center of Indiana   (United States)

^d ST JOSEPH S HOSPITAL HEALTH CENTER   (United States)

^e PRESBYTERIAN HOSPITAL   (United States)

^f St Patrick's Hospital   (United States)

^g NewYork Presbyterian Hospital   (United States)

Author keywords

Everolimus eluting stent; Non Q wave myocardial infarction; Paclitaxel eluting stent; Side branch occlusion

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; TICLOPIDINE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROSPECTIVE STUDY; Q WAVE; SIDE BRANCH OCCLUSION; STENT THROMBOSIS; TREATMENT DURATION;

EID: 79954538234     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/eijv6supja8     Document Type: Article

References (27)

1. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007;50:463-70. (Pubitemid 47088133)
2. Schofer J, Bode C, Silber S. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies. Herz 2004;29:195-200. (Pubitemid 38495894)
3. Rogan SV, Arablinskii AV, Solov'ev OP. [Stent thrombosis in patients with myocardial infarction]. Kardiologiia 2003;43:77-81.
4. Rodriguez A. Stent trials in acute myocardial infarction. J Invasive Cardiol 1999;11:56-9; discussion 59-60.
5. Mehta RH, Bates ER. Coronary stent implantation in acute myocardial infarction. Am Heart J 1999;137:603-11. (Pubitemid 29173571)
6. Sperling RT, Ho K, James D, Laham R, Gibson M, Carrozza J. Treatment of stent-jailed side branch stenoses with rotational atherectomy. J Invasive Cardiol 2006;18:354-8. (Pubitemid 44178968)
7. Jang JS, Hong MK, Park DW, Lee SW, Kim YH, Lee CW, Kim JJ, Park SW, Park SJ. Impact of periprocedural myonecrosis on clinical events after implantation of drug-eluting stents. Int J Cardiol 2007;129:368-72.
8. Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi MJ. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. Catheter Cardiovasc Interv 2004;61:472-6. (Pubitemid 38419132)
9. Holmes DR Jr, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, Williams DO, Cowley MJ, Faxon DP, Kent KM, Bentivoglio L. G, Detre K. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1988;12:1149-1155.
10. Meier B, Gruentzig AR, King SB 3rd, Douglas JS Jr, Hollman J, Ischinger T, Aueron F, Galan K. Risk of side branch occlusion during coronary angioplasty. Am J Cardiol 1984;53:10-14. (Pubitemid 14217499)
11. Popma JJ, Mauri L, O'Shaughnessy C, Overlie P, McLaurin B, Almonacid A, Kirtane A, Leon MB. Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents. Circ Cardiovasc Intervent 2009;2:133-139.
12. Fischman DL, Savage MP, Leon MB, Schatz RA, Ellis S, Cleman MW, Hirshfeld JW, Teirstein P, Bailey S, Walker CM, Goldberg S. Fate of lesion-related side branches after coronary artery stenting. J Am Coll Cardiol 1993;22:1641-6. (Pubitemid 23336717)
13. Mazur W, Grinstead WC, Hakim AH, Dabaghi SF, Abukhalil JM, Ali NM, Joseph J, French BA, Raizner AE. Fate of side branches after intracoronary implantation of the Gianturco-Roubin flex-stent for acute or threatened closure after percutaneous transluminal coronary angioplasty. Am J Cardiol 1994;74:1207-10.
14. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-23. (Pubitemid 41352109)
15. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. (Pubitemid 37186209)
16. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 2008;299:1903-13. (Pubitemid 351574920)
17. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation 2009;119:680-6.
18. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators. Investigators S I. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 2008;299:1903-13. (Pubitemid 351574920)
19. Donald E. Cutlip, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, on behalf of the Academic Research Consortium. Academic Research Consortium. Clinical endpoints in coronary stent trials - a case for standardized definitions. Circulation 2007;115:2344-51.
20. Aliabadi D, Tilli FV, Bowers TR, Benzuly KH, Safian RD, Goldstein JA, Grines CL, O'Neill WW. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol 1997;80:994-7. (Pubitemid 27459196)
21. Kralev S, Poerner TC, Basorth D, Lang S, Wolpert C, Haghi D, Borggrefe M, Haase KK, Süselbeck T. Side branch occlusion after coronary stent implantation in patients presenting with ST-elevation myocardial infarction: clinical impact and angiographic predictors. Am Heart J 2006;151:153-7. (Pubitemid 41815346)
22. Morimoto S, Hiramitsu S, Yamada K, Uemura A, Kubo N, Mizuno Y. Lesions in side branches of arteries having undergone percutaneous transluminal coronary angioplasty: a histopathologic study. Am Heart J 1990;120:864-72. (Pubitemid 20346151)
23. Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, Rubartelli P, Battaglia S, Niccoli L, Steffenino G, Ardissino D; Italian 'Atherosclerosis, Thorombosis, and Vascular Biology' and 'Society for Invasive Cardiology-GISE' Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 2005;26:1494-8.
24. Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina. Cardiology 2009;113:122-31.
25. Okmen E, Kasikcioglu H, Sanli A, Uyarel H, Cam N. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. J Invasive Cardiol 2005;17:63-7 (Pubitemid 41724720)
26. Kuchulakanti P, Rha SW, Satler LF, Suddath WO, Pichard AD, Kent KM, Pakala R, Canos DA, Pinnow EE, Waksman R. Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis. Am J Cardiol 2004;93: 1394-7. (Pubitemid 38692469)
27. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, Bonow RO. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003;145:522-8. (Pubitemid 36390500)